Leflunomide for Polyomavirus Type BK Nephropathy
Leflunomide for Polyomavirus Type BK Nephropathy
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
Polyomavirus type BK nephropathy is an aggressively destructive disease occurring in up to 8 percent of patients with renal allografts,
1
,
2
with rates of graft loss within one year of 30 to 65 percent.
3
,
4
There is no therapy with proven efficacy. Leflunomide (Arava), approved for the treatment of rheum...
Alternative Titles
Full title
Leflunomide for Polyomavirus Type BK Nephropathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67540032
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67540032
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJM200503173521125
